LAPTM5 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85200
Key Product Details
Species Reactivity
Validated:
Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Summary for LAPTM5 Antibody
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of rat LAPTM5. Peptide sequence: CSSYMEVPTYLNFKSMNHMNYLPSQEGMPRSQFINMMLIFSVAFITVLIL The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for LAPTM5 Antibody
Western Blot: LAPTM5 Antibody [NBP2-85200]
Western Blot: LAPTM5 Antibody [NBP2-85200] - Host: Rabbit. Target Name: LAPTM5. Sample Tissue: Rat Liver lysates. Antibody Dilution: 1.0ug/mlApplications for LAPTM5 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: LAPTM5
Alternate Names
CD40-ligand-activated specific transcripts, CLAST6, FLJ61683, FLJ97251, human retinoic acid-inducible E3 protein, KIAA0085, lysosomal associated multispanning membrane protein 5, lysosomal multispanning membrane protein 5, lysosomal protein transmembrane 5, Lysosomal-associated multitransmembrane protein 5, lysosomal-associated transmembrane protein 5, MGC125860, MGC125861, Retinoic acid-inducible E3 protein
Gene Symbol
LAPTM5
Additional LAPTM5 Products
Product Specific Notices for LAPTM5 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...